Boston Scientific (BSX) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.99 | 3.05 | 2.50 | 2.73 | 2.78 | 2.00 | |||
| Changes by years, y/y, % | -42% | +2% | -18% | +9% | +2% | -11.7% | |||
Boston Scientific. Debt/EBITDA
Boston Scientific. Debt/EBITDA, changes, %
Boston Scientific (BSX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 2.64 | 2.44 | 2.14 | 2.11 | 2.00 | 2.00 | ||
| Changes by years, y/y, % | +11% | +11% | -8% | -23% | -24% | |||
| Changes by quarters, q/q, % | -3% | -8% | -12% | -1% | -6% | |||